Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling

Research output: Contribution to journalArticlepeer-review

404 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling'. Together they form a unique fingerprint.

Medicine and Dentistry